Literature DB >> 3974805

Successful carnitine treatment in two siblings having lipid storage myopathy with hypertrophic cardiomyopathy.

T Matsuishi, K Hirata, K Terasawa, H Kato, M Yoshino, E Ohtaki, F Hirose, I Nonaka, N Sugiyama, K Ohta.   

Abstract

Two Japanese siblings had lipid storage myopathy with hypertrophic cardiomyopathy (HCM). They had slowly progressive muscle weakness and ventricular hypertrophy of the heart evidenced by electrocardiography and echocardiography. Their developmental milestones were normal until three years of age when mild weakness in the lower limbs became evident. Laboratory examination showed transient high creatine kinase levels (CK) and hyperammonemia. Histochemical investigation on the muscles revealed abnormal accumulation of sudanophilic lipid droplets predominantly in type 1 fibers, type 2 A fiber atrophy and type 2 B fiber deficiency. In case 1, excessive lipid droplets were also observed in the biopsied cardiac muscle. Carnitine was decreased in the skeletal muscles and the serum. Treatment with DL-carnitine to both cases resulted in marked clinical improvement and decreased lipid droplets in the muscles.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3974805     DOI: 10.1055/s-2008-1052536

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  13 in total

Review 1.  Primary lipid cardiomyopathy.

Authors:  A Zimmermann; P Wyss; F Stocker
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

2.  Exome sequencing identifies primary carnitine deficiency in a family with cardiomyopathy and sudden death.

Authors:  Najim Lahrouchi; Elisabeth M Lodder; Maria Mansouri; Rafik Tadros; Layla Zniber; Najlae Adadi; Sally-Ann B Clur; Karin Y van Spaendonck-Zwarts; Alex V Postma; Abdelaziz Sefiani; Ilham Ratbi; Connie R Bezzina
Journal:  Eur J Hum Genet       Date:  2017-03-15       Impact factor: 4.246

3.  A regional study of presentation and outcome of hypertrophic cardiomyopathy in infants.

Authors:  J R Skinner; A Manzoor; A M Hayes; H S Joffe; R P Martin
Journal:  Heart       Date:  1997-03       Impact factor: 5.994

Review 4.  [Lipid storage myopathies. A clinical and pathobiochemical challenge].

Authors:  T Skuban; T Klopstock; B Schoser
Journal:  Nervenarzt       Date:  2010-12       Impact factor: 1.214

Review 5.  l-Carnitine. A preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism.

Authors:  K L Goa; R N Brogden
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

Review 6.  Primary (genetic) cardiomyopathies in infancy. A survey of possible disorders and guidelines for diagnosis.

Authors:  A Kohlschütter; G Hausdorf
Journal:  Eur J Pediatr       Date:  1986-12       Impact factor: 3.183

7.  Oral carnitine therapy in children with cystinosis and renal Fanconi syndrome.

Authors:  W A Gahl; I Bernardini; M Dalakas; W B Rizzo; G S Harper; J M Hoeg; O Hurko; J Bernar
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

8.  Mitochondrial abnormalities of muscle tissue in mice with juvenile visceral steatosis associated with systemic carnitine deficiency.

Authors:  J Miyagawa; M Kuwajima; T Hanafusa; K Ozaki; H Fujimura; A Ono; R Uenaka; I Narama; T Oue; K Yamamoto
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 9.  Primary carnitine deficiency and cardiomyopathy.

Authors:  Lijun Fu; Meirong Huang; Shubao Chen
Journal:  Korean Circ J       Date:  2013-12       Impact factor: 3.243

10.  Twin Brothers with Carnitine Membrane Transporter Deficiency: A Case Study.

Authors:  Elham Hashemi Dehkordi; Payam Sobhani; Nabiolah Asadpour; Mahin Hashemipour; Neda Mostofizadeh
Journal:  Adv Biomed Res       Date:  2018-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.